After initial evaluation of the biological effects of YAP1 inhibition via siRNA pool on GBC cell lines, we studied the in vitro effects of VP, a known suppressor of YAP1-TEAD complex with great potential to be used in cancer therapy [16]. The gene discussed is YAP1; the disease is cancer.